A detailed history of Verdence Capital Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Verdence Capital Advisors LLC holds 13,139 shares of AMGN stock, worth $3.81 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
13,139
Previous 13,952 5.83%
Holding current value
$3.81 Million
Previous $4.36 Million 2.89%
% of portfolio
0.35%
Previous 0.39%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$309.38 - $337.38 $251,525 - $274,289
-813 Reduced 5.83%
13,139 $4.23 Million
Q2 2024

Jul 25, 2024

BUY
$262.75 - $319.31 $417,247 - $507,064
1,588 Added 12.84%
13,952 $4.36 Million
Q1 2024

Apr 25, 2024

SELL
$268.87 - $324.56 $150,298 - $181,429
-559 Reduced 4.33%
12,364 $3.52 Million
Q4 2023

Jan 31, 2024

SELL
$255.7 - $288.46 $539,015 - $608,073
-2,108 Reduced 14.02%
12,923 $3.72 Million
Q3 2023

Oct 25, 2023

BUY
$218.65 - $271.46 $720,014 - $893,917
3,293 Added 28.05%
15,031 $4.04 Million
Q2 2023

Jul 28, 2023

BUY
$214.27 - $253.37 $413,541 - $489,004
1,930 Added 19.68%
11,738 $2.61 Million
Q1 2023

Apr 24, 2023

BUY
$225.79 - $275.2 $411,840 - $501,964
1,824 Added 22.85%
9,808 $2.37 Million
Q4 2022

Jan 20, 2023

SELL
$229.03 - $291.01 $469,053 - $595,988
-2,048 Reduced 20.41%
7,984 $0
Q3 2022

Nov 15, 2022

BUY
$224.46 - $253.15 $274,290 - $309,349
1,222 Added 13.87%
10,032 $2.26 Million
Q2 2022

Aug 08, 2022

SELL
$230.71 - $256.74 $249,628 - $277,792
-1,082 Reduced 10.94%
8,810 $2.14 Million
Q1 2022

May 02, 2022

BUY
$219.27 - $242.57 $228,698 - $253,000
1,043 Added 11.79%
9,892 $2.39 Million
Q4 2021

Jan 26, 2022

BUY
$198.88 - $227.6 $244,821 - $280,175
1,231 Added 16.16%
8,849 $1.99 Million
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $566,336 - $663,531
2,668 Added 53.9%
7,618 $1.62 Million
Q2 2021

Aug 06, 2021

BUY
$233.58 - $259.14 $446,838 - $495,734
1,913 Added 62.99%
4,950 $1.21 Million
Q1 2021

May 11, 2021

BUY
$221.91 - $258.6 $70,789 - $82,493
319 Added 11.74%
3,037 $756,000
Q4 2020

Feb 12, 2021

SELL
$216.38 - $257.67 $401,817 - $478,493
-1,857 Reduced 40.59%
2,718 $625,000
Q3 2020

Nov 09, 2020

SELL
$234.65 - $260.95 $573,484 - $637,761
-2,444 Reduced 34.82%
4,575 $1.16 Million
Q2 2020

Aug 11, 2020

SELL
$197.81 - $242.74 $70,024 - $85,929
-354 Reduced 4.8%
7,019 $1.66 Million
Q1 2020

May 13, 2020

BUY
$182.24 - $241.7 $153,446 - $203,511
842 Added 12.89%
7,373 $1.5 Million
Q4 2019

Feb 03, 2020

BUY
$189.21 - $243.2 $271,705 - $349,235
1,436 Added 28.18%
6,531 $1.57 Million
Q3 2019

Mar 06, 2020

SELL
$174.11 - $208.62 $138,591 - $166,061
-796 Reduced 13.51%
5,095 $986,000
Q2 2019

Mar 02, 2020

SELL
$166.7 - $195.41 $58,344 - $68,393
-350 Reduced 5.61%
5,891 $1.09 Million
Q1 2019

Mar 02, 2020

BUY
$180.87 - $203.88 $160,974 - $181,453
890 Added 16.63%
6,241 $1.19 Million
Q4 2018

Feb 25, 2020

BUY
$178.4 - $208.25 $150,034 - $175,138
841 Added 18.65%
5,351 $1.04 Million
Q3 2018

Feb 25, 2020

BUY
$185.29 - $208.89 $490,462 - $552,931
2,647 Added 142.08%
4,510 $935,000
Q2 2018

Feb 11, 2020

BUY
$166.05 - $186.51 $100,294 - $112,652
604 Added 47.97%
1,863 $344,000
Q1 2018

Jan 30, 2020

SELL
$169.43 - $198.0 $32,699 - $38,214
-193 Reduced 13.29%
1,259 $215,000
Q4 2017

Jan 30, 2020

BUY
$168.79 - $188.59 $245,083 - $273,832
1,452
1,452 $252,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $155B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Verdence Capital Advisors LLC Portfolio

Follow Verdence Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verdence Capital Advisors LLC with notifications on news.